Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Consulting agrmnt
CC transcript
Asset disposition
Director departure
Appointed COO
Appointed director

DENDREON CORP (DNDNQ) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/22/2012 PRN Genesis Biopharma Names Biotech Industry Veteran Hans E. Bishop as Executive Chairman of the Board
06/30/2011 PRN Dendreon Announces Increased Capacity and Significant Reimbursement Decisions Supporting Broad Availability of PROVENGE
06/29/2011 PRN FDA Approves Dendreon's Los Angeles Cancer Immunotherapy Manufacturing Facility
05/20/2011 PRN Dendreon Announces Webcast Presentation at Upcoming Conferences
05/18/2011 PRN Dendreon Announces Presentation of PROVENGE Data at the 2011 American Society of Clinical Oncology Annual Meeting
05/18/2011 PRN Dendreon Announces Clinical Trial Plans for PROVENGE and DN24-02 at the American Society of Clinical Oncology Annual Meeting
04/28/2011 PRN Dendreon Announces Webcast Presentations at Upcoming Conferences
04/14/2011 PRN Dendreon to Host Conference Call on May 2, 2011 to Announce First Quarter 2011 Financial Results
04/06/2011 PRN Dendreon Announces Presentation of Data at the American Association of Cancer Research Annual Meeting
03/30/2011 PRN Dendreon Statement on CMS Proposed Decision Memo for PROVENGE®
03/29/2011 PRN Dendreon Announces Webcast Presentations at Upcoming Conferences
03/10/2011 PRN Dendreon Expands Launch of PROVENGE
03/01/2011 PRN Dendreon Reports Fourth Quarter and 2010 Year End Financial Results
02/24/2011 PRN Dendreon Announces Webcast Presentations at Four Upcoming Conferences
02/17/2011 PRN Dendreon Announces Presentation of PROVENGE Data at the 2011 Genitourinary Cancers Symposium Annual Meeting
07/28/2010 PRN New England Journal of Medicine Publishes Data from Pivotal Phase 3 PROVENGE IMPACT Study
07/12/2010 PRN Dendreon to Host Conference Call on August 3rd to Announce Second Quarter Financial Results
06/30/2010 PRN Dendreon Statement on CMS National Coverage Analysis
05/10/2010 PRN Dendreon Reports First Quarter 2010 Financial Results
04/30/2010 PRN Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
04/29/2010 PRN FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer
04/15/2010 PRN Dendreon Appoints Richard Ranieri as Senior Vice President of Human Resources
04/08/2010 PRN Dendreon Appoints Varun Nanda Senior Vice President of Global Commercial Operations

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy